loading
Schlusskurs vom Vortag:
$41.14
Offen:
$41.14
24-Stunden-Volumen:
279.55K
Relative Volume:
0.68
Marktkapitalisierung:
$3.07B
Einnahmen:
$384.10M
Nettoeinkommen (Verlust:
$-9.07M
KGV:
-289.61
EPS:
-0.14
Netto-Cashflow:
$11.10M
1W Leistung:
-0.11%
1M Leistung:
+2.65%
6M Leistung:
+36.19%
1J Leistung:
+89.37%
1-Tages-Spanne:
Value
$40.05
$41.60
1-Wochen-Bereich:
Value
$39.79
$42.32
52-Wochen-Spanne:
Value
$17.82
$42.98

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile

Name
Firmenname
Kiniksa Pharmaceuticals International Plc
Name
Telefon
(781) 431-9100
Name
Adresse
23 OLD BOND STREET, FLOOR 3, LONDON
Name
Mitarbeiter
315
Name
Twitter
@kiniksa
Name
Nächster Verdiensttermin
2024-10-29
Name
Neueste SEC-Einreichungen
Name
KNSA's Discussions on Twitter

Vergleichen Sie KNSA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
KNSA
Kiniksa Pharmaceuticals International Plc
40.55 3.12B 384.10M -9.07M 11.10M -0.14
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
118.07 51.01B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.37 45.05B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.46 41.46B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
29.80 32.77B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
484.86 20.51B 3.08B 1.24B 1.07B 25.61

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-29 Eingeleitet TD Cowen Buy
2025-03-13 Eingeleitet Citigroup Buy
2024-09-13 Eingeleitet Jefferies Buy
2024-05-03 Eingeleitet Wells Fargo Overweight
2020-06-29 Bestätigt BofA Securities Buy
2020-04-01 Eingeleitet BofA/Merrill Buy
2019-03-11 Eingeleitet Barclays Overweight
2018-12-12 Bestätigt Wedbush Outperform
2018-06-19 Eingeleitet JMP Securities Mkt Outperform
Alle ansehen

Kiniksa Pharmaceuticals International Plc Aktie (KNSA) Neueste Nachrichten

pulisher
Dec 10, 2025

Kiniksa Pharma CFO Ragosa sells shares worth $1.77m By Investing.com - Investing.com UK

Dec 10, 2025
pulisher
Dec 10, 2025

Jump Financial LLC Takes Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 10, 2025
pulisher
Dec 08, 2025

Kiniksa Pharmaceuticals International, plc $KNSA Shares Bought by Walleye Capital LLC - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

Arrowstreet Capital Limited Partnership Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 08, 2025
pulisher
Dec 06, 2025

Fisher Asset Management LLC Has $2.83 Million Stock Position in Kiniksa Pharmaceuticals International, plc $KNSA - Defense World

Dec 06, 2025
pulisher
Dec 03, 2025

Wedbush Reiterates Outperform Rating for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Traders Buy High Volume of Call Options on Kiniksa Pharmaceuticals International (NASDAQ:KNSA) - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Franklin Resources Inc. Acquires 41,632 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

Kiniksa Pharmaceuticals International’s (KNSA) “Outperform” Rating Reaffirmed at Wedbush - Defense World

Dec 03, 2025
pulisher
Dec 01, 2025

Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Dec 01, 2025
pulisher
Nov 29, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 29, 2025
pulisher
Nov 28, 2025

Kiniksa (KNSA) Q3 2025 Earnings Call Transcript - The Globe and Mail

Nov 28, 2025
pulisher
Nov 27, 2025

Wall Street Analysts Think Kiniksa Pharmaceuticals International, plc (KNSA) Could Surge 29.3%: Read This Before Placing a Bet - MSN

Nov 27, 2025
pulisher
Nov 27, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month HighTime to Buy? - MarketBeat

Nov 27, 2025
pulisher
Nov 25, 2025

AXQ Capital LP Makes New $289,000 Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 25, 2025
pulisher
Nov 23, 2025

200,574 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Purchased by Hillsdale Investment Management Inc. - MarketBeat

Nov 23, 2025
pulisher
Nov 21, 2025

Catalyst Funds Management Pty Ltd Takes $493,000 Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 21, 2025
pulisher
Nov 20, 2025

Insider Selling: Kiniksa Pharmaceuticals International (NASDAQ:KNSA) COO Sells 12,470 Shares of Stock - MarketBeat

Nov 20, 2025
pulisher
Nov 20, 2025

SG Americas Securities LLC Acquires 127,126 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 20, 2025
pulisher
Nov 20, 2025

Kiniksa Pharma COO Tessari sells shares worth $514,224 By Investing.com - Investing.com India

Nov 20, 2025
pulisher
Nov 19, 2025

Kiniksa Pharma COO Tessari sells shares worth $514,224 - Investing.com

Nov 19, 2025
pulisher
Nov 19, 2025

[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity - Stock Titan

Nov 19, 2025
pulisher
Nov 19, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 52-Week HighTime to Buy? - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

Los Angeles Capital Management LLC Sells 36,570 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews

Nov 19, 2025
pulisher
Nov 18, 2025

Kiniksa Pharmaceuticals International, plc (KNSA) Presents at Jefferies London Healthcare Conference 2025Slideshow (NASDAQ:KNSA) 2025-11-18 - Seeking Alpha

Nov 18, 2025
pulisher
Nov 18, 2025

Savant Capital LLC Invests $398,000 in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 18, 2025
pulisher
Nov 16, 2025

Mark Ragosa Sells 19,900 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat

Nov 16, 2025
pulisher
Nov 16, 2025

Kiniksa Rides ARCALYST Growth To Outpace The S&P 500 - Finimize

Nov 16, 2025
pulisher
Nov 14, 2025

Kiniksa Pharmaceuticals CFO Sells Shares - TradingView

Nov 14, 2025
pulisher
Nov 14, 2025

Exploring High Growth Tech Stocks in the US Market - Yahoo Finance

Nov 14, 2025
pulisher
Nov 13, 2025

Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London - The Manila Times

Nov 13, 2025
pulisher
Nov 12, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Increases 5.3% This Week, Taking Five-year Gains to 166% - 富途牛牛

Nov 12, 2025
pulisher
Nov 12, 2025

Kiniksa (NASDAQ: KNSA) to present at Jefferies Healthcare Conf.; live webcast Nov. 17 - Stock Titan

Nov 12, 2025
pulisher
Nov 11, 2025

Connor Clark & Lunn Investment Management Ltd. Has $17.26 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 11, 2025
pulisher
Nov 11, 2025

Kiniksa Pharmaceuticals International, plc $KNSA Shares Acquired by Acadian Asset Management LLC - MarketBeat

Nov 11, 2025
pulisher
Nov 09, 2025

Fox Run Management L.L.C. Buys 24,391 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Nov 09, 2025
pulisher
Nov 06, 2025

Vanguard Group Inc Reduces Stake in Kiniksa Pharmaceuticals Inte - GuruFocus

Nov 06, 2025
pulisher
Nov 05, 2025

John Paolini Sells 82,542 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat

Nov 05, 2025
pulisher
Nov 05, 2025

Kiniksa Pharmaceuticals International, plc (KNSA) Q3 Earnings Miss Estimates - MSN

Nov 05, 2025
pulisher
Nov 05, 2025

We Think Kiniksa Pharmaceuticals International's (NASDAQ:KNSA) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance

Nov 05, 2025

Finanzdaten der Kiniksa Pharmaceuticals International Plc-Aktie (KNSA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.88
price down icon 4.87%
$21.30
price up icon 4.26%
drug_manufacturers_specialty_generic RDY
$13.86
price up icon 0.29%
$11.60
price up icon 3.66%
$155.63
price up icon 0.39%
$484.86
price up icon 1.78%
Kapitalisierung:     |  Volumen (24h):